ArticleCureus2025
Coronary Microvascular Dysfunction and Risk of Cardiovascular Events in Type 2 Diabetes Without Obstructive Coronary Artery Disease (CAD): A Prospective Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Coronary Artery Spasm in Patients with Type 2 Diabetes Mellitus.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary microvascular dysfunction (CMD) is increasingly recognized as a contributor to adverse cardiovascular outcomes in patients with diabetes mellitus (DM), yet it remains underdiagnosed. This is largely because routine evaluation is limited by the need for complex, time-consuming, and not routinely performed diagnostic methods, which primarily focus on macrovascular disease.
objectiveTo prospectively evaluate the association between CMD and major adverse cardiovascular events (MACE) - defined as myocardial infarction, hospitalization for heart failure, and cardiovascular death - in patients with type 2 diabetes without obstructive coronary artery disease (CAD). METHODOLOGY: We conducted a prospective observational study at Shifa College of Medicine, Islamabad, from August 2022 to July 2024. A total of 264 adults with type 2 DM of five or more years' duration and non-obstructive CAD (<50% stenosis on angiography/CT) were consecutively enrolled. Exclusion criteria included type 1 diabetes, left ventricular ejection fraction <50%, significant structural or valvular heart disease, prior revascularization, acute coronary syndrome at baseline, and incomplete data. CMD was diagnosed using transthoracic Doppler echocardiography, with coronary flow reserve (CFR) <2.0 considered abnormal in accordance with current consensus. CFR was measured in the left anterior descending artery by two independent operators blinded to outcomes, with reproducibility assessed in a subset. Patients were followed for 24 months; loss to follow-up (7.95%) was excluded from survival analyses. Multivariate Cox regression adjusting for age, sex, hypertension, dyslipidemia, BMI, and diabetes duration was performed, with hazard ratios (HR) and 95% confidence intervals (CI) reported.
resultsAmong 264 patients (mean age 58.0 ± 8.1 years, 56.8% male), 142 (53.8%) had CMD. Follow-up was completed in 243 patients (CMD: 128, non-CMD: 115). CMD patients experienced significantly more MACE (29.7% vs. 10.4%,
conclusionCMD strongly and independently predicts long-term adverse cardiovascular outcomes in patients with type 2 diabetes without obstructive CAD, even after adjusting for conventional risk factors such as hypertension and smoking. Early detection of CMD using CFR assessment may improve risk stratification and guide preventive management in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.